Question 1

How many institutions own KAPA stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own KAPA shares is 15, representing 8.13% of the company's common stock.

Question 2

Who are the major shareholders selling Kairos Pharma, Ltd. stock?

Accepted Answer

TOWER RESEARCH CAPITAL LLC (TRC), in the last quarter, reduced its stake in KAPA by -6.27% restricting it's holding to 3.96 thousand shares of worth nearly $2.22K. TWO SIGMA INVESTMENTS, LP also lessened -57.94% of the KAPA shares from its portfolio, reducing its holding to 39.54 thousand shares of worth $22.11K. BANK OF AMERICA CORP /DE/ also shunned KAPA shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Question 3

Investors who are buying KAPA stock?

Accepted Answer

As per its latest 13F filing, CITIGROUP INC increased its stake in KAPA by 100% in the last quarter. The institutional holder raised its holding to 10 shares having worth more than $6.00.  also added 100% more shares of KAPA to its portfolio, raising its holding to 231.88 thousand shares of worth $129.62K. GEODE CAPITAL MANAGEMENT, LLC also increased its KAPA shares holding by 52.8% which brought its holding to 111.29 thousand shares worth $62.21K.

Question 4

KAPA's major insiders: who are they?

Accepted Answer

The insider with the most stakes in KAPA is Yu John S , CEO and Chairman at the company. Additionally, KAPA stock is highly held by VP of Research and Development Murali Ramachandran and Chief Financial Officer Samuelson Doug among others.

Question 5

Did an insider recently sell KAPA stock?

Accepted Answer

Company executives, directors, and other insiders own 39.86% percent of Kairos Pharma, Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which KAPA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Question 6

Which insider recently purchased KAPA stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Kairos Pharma, Ltd. insiders have bought stock, totalling 0 shares

Question 7

How much of KAPA does insiders own?

Accepted Answer

Around 0 Kairos Pharma, Ltd. shares are held by insiders, which represents about 39.86% of KAPA stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

KAPA CEO and Chairman, Yu John S holds the largest portfolio of the company's shares. KAPA shares owned by Yu total nearly 5.34 million.

Question 9

Which institution holds the most shares in KAPA?

Accepted Answer

TOWER RESEARCH CAPITAL LLC (TRC) is the largest institutional owner in KAPA which holds 3.96 thousand shares worth $2.22K or 0.02% of the total KAPA shares outstanding followed by CITIGROUP INC with ownership of 10 shares representing 0% of the KAPA ownership.  is the third largest stakeholder with 231.88 thousand shares or 1.1% of the ownership worth more than $129.62K.

Question 10

Is Kairos Pharma, Ltd. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the KAPA is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on KAPA's shares?

Accepted Answer

Number of KAPA shares short is 869.28K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding KAPA shares are there?

Accepted Answer

As of today, 20.74M shares of KAPA are outstanding.

Question 13

Is there many float in KAPA stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, KAPA has 11.81M shares in float.

Question 14

KAPA short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for KAPA is 0.07.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	3.96K	2.22K	-265	-6.27%
Mar 31, 2026	CITIGROUP INC	0%	10	6	10	+100.00%
Mar 31, 2026		1.1%	231.88K	129.62K	231.88K	+100.00%
Mar 31, 2026	GEODE CAPITAL MANAGEMENT, LLC	0.53%	111.29K	62.21K	38.46K	+52.80%
Mar 31, 2026	VANGUARD FIDUCIARY TRUST CO	0.3%	63.88K	35.71K	63.88K	+100.00%
Mar 31, 2026	APTUS CAPITAL ADVISORS, LLC	0.21%	44.29K	24.76K	0	0
Mar 31, 2026	TWO SIGMA INVESTMENTS, LP	0.19%	39.54K	22.11K	-54.47K	-57.94%
Mar 31, 2026	STATE STREET CORP	0.11%	24.1K	13.47K	0	0
Mar 31, 2026	TWO SIGMA SECURITIES, LLC	0.08%	16.25K	9.08K	16.25K	+100.00%
Mar 31, 2026	BANK OF AMERICA CORP /DE/	0%	0	-	-134	-100.00%
Mar 31, 2026	ADVISOR GROUP HOLDINGS, INC.	0%	0	-	-13.05K	-100.00%
Mar 31, 2026	XTX TOPCO LTD	0%	0	-	-48.49K	-100.00%
Mar 31, 2026	SEVENBRIDGE FINANCIAL GROUP, LLC	0.21%	44.29K	30.33K	0	0
Mar 31, 2026	HRT FINANCIAL LP	0.1%	21.58K	12K	256	+1.20%
Mar 31, 2026	CITADEL ADVISORS LLC	0%	0	-	-321.74K	-100.00%
Mar 31, 2026	VIRTU FINANCIAL LLC	0%	0	-	-20.28K	-100.00%

Insiders	Designation	Shares Held
YU JOHN S	CEO and Chairman	5.34M
MURALI RAMACHANDRAN	VP of Research and Development	133.06K
SAMUELSON DOUG	Chief Financial Officer	60.8K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 25, 2024	MURALI RAMACHANDRAN	PURCHASE	1.59	200	318	133.06K
Nov 22, 2024	SAMUELSON DOUG	PURCHASE	1.50	2.5K	3.75K	60.8K
Nov 20, 2024	YU JOHN S	PURCHASE	1.44	4K	5.76K	5.34M

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	3.96K	2.22K	-265	-6.27%
Mar 31, 2026	CITIGROUP INC	0%	10	6	10	+100.00%
Mar 31, 2026		1.1%	231.88K	129.62K	231.88K	+100.00%
Mar 31, 2026	GEODE CAPITAL MANAGEMENT, LLC	0.53%	111.29K	62.21K	38.46K	+52.80%
Mar 31, 2026	VANGUARD FIDUCIARY TRUST CO	0.3%	63.88K	35.71K	63.88K	+100.00%
Mar 31, 2026	APTUS CAPITAL ADVISORS, LLC	0.21%	44.29K	24.76K	0	0
Mar 31, 2026	TWO SIGMA INVESTMENTS, LP	0.19%	39.54K	22.11K	-54.47K	-57.94%
Mar 31, 2026	STATE STREET CORP	0.11%	24.1K	13.47K	0	0
Mar 31, 2026	TWO SIGMA SECURITIES, LLC	0.08%	16.25K	9.08K	16.25K	+100.00%
Mar 31, 2026	BANK OF AMERICA CORP /DE/	0%	0	-	-134	-100.00%
Mar 31, 2026	ADVISOR GROUP HOLDINGS, INC.	0%	0	-	-13.05K	-100.00%
Mar 31, 2026	XTX TOPCO LTD	0%	0	-	-48.49K	-100.00%
Mar 31, 2026	SEVENBRIDGE FINANCIAL GROUP, LLC	0.21%	44.29K	30.33K	0	0
Mar 31, 2026	HRT FINANCIAL LP	0.1%	21.58K	12K	256	+1.20%
Mar 31, 2026	CITADEL ADVISORS LLC	0%	0	-	-321.74K	-100.00%
Mar 31, 2026	VIRTU FINANCIAL LLC	0%	0	-	-20.28K	-100.00%

Insiders	Designation	Shares Held
YU JOHN S	CEO and Chairman	5.34M
MURALI RAMACHANDRAN	VP of Research and Development	133.06K
SAMUELSON DOUG	Chief Financial Officer	60.8K

KAPA Stock Ownership Breakdown

Kairos Pharma

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions